크레오에스지

040350KOSDAQ

54.3 / 100

Reference Date: 2026-09-08

Financial Score12.0 / 40

News Sentiment21.3 / 25

Momentum9.0 / 20

Disclosure12.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 37.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Creo SG operates in three main business segments: financial IT solutions, biotech vaccine development, and real estate operations. The solution segment provides core banking systems to banks and non-banks, while the biotech segment focuses on developing vaccines for AIDS, COVID-19, and superbugs, though it currently generates no revenue. The real estate segment manages properties through a subsidiary.

Number of Employees

48people

Average Salary

57.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.94Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE

-17.52Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

69.35Industry Average 100.005.0Point

Lower than industry avg (good)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼32.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -30.1% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
크레오에스지, 모더나 암백신 3상 '잭팟'에 주목…'백신→항암' 플랫....
크레오스지의 면역항암 기술이 모더나 암백신 성공으로 주목받아 긍정적인 시장 반응 예상.
Positive
크레오에스지, SUV-MAP™ 플랫폼으로 차세대 에볼라 변종 대응 나선...
크레오스지는 SUV-MAP 플랫폼을 통해 에볼라 변종 대응 백신 개발로 미래 대응 능력을 강화했다.

Detailed Momentum

52-week position3.0Point

52w lower range (35%)

Current 4,620Won52-week high 11,95052-week low 556

1-month return0.0Point

1m -36.97% (strong drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

6 totalPositive 1Neutral 5Negative 0

Positive[기재정정]최대주주변경을수반하는주식담보제공계약체결2026-09-04
Neutral조회공시요구(현저한시황변동)에대한답변(중요정보없음)2026-08-31
Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
Neutral주식등의대량보유상황보고서(일반)2026-08-25
Neutral반기보고서 (2026.06)2026-08-14